GRMN
Garmin Ltd.
GRMN's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over GRMN overall, supported by stronger valuation and stronger modeled upside.
GRMN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
GRMN's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
GRMN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $200 | -30% |
| Fair | 23x | $242 | -16% |
| Forward | 26x | $286 | — |
| Expensive | 27x | $284 | -0.9% |
| Current | 27x | $286 | — |
Historical ranges are pointers, not guarantees.
GRMN's PE is in its expensive range at 27x. If earnings grow as analysts expect, today's price would be 26x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over GRMN in the historical PE scenario, which offers more potential upside but is not a forecast.
GRMN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
GRMN has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
GRMN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.12 | +6.8% |
| Q3 2026 | $10.41 | +28% |
| Q2 2026 | $9.69 | +20% |
| Q1 2026 | $8.96 | +18% |
| Q4 2025 | $8.59 | +18% |
| Q3 2025 | $8.11 | +2.9% |
| Q2 2025 | $8.10 | +13% |
| Q1 2025 | $7.59 | +7.1% |
| Q4 2024 | $7.30 | +8.8% |
GRMN's earnings per share have climbed steadily: $10.41 over the past year, up 28% from the year before, and higher year over year for 13 quarters in a row.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over GRMN on earnings, with stronger typical year-over-year growth.
GRMN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +12% |
| Q2 2026 | $2B | +11% |
| Q1 2026 | $1.8B | +14% |
| Q4 2025 | $2.1B | +17% |
| Q3 2025 | $1.8B | +12% |
| Q2 2025 | $1.8B | +20% |
| Q1 2025 | $1.5B | +11% |
| Q4 2024 | $1.8B | +23% |
GRMN's revenue has grown year over year for 14 quarters in a row: $2B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +5 points |
| Q2 2026 | 30% | +4.4 points |
| Q1 2026 | 25% | +2.9 points |
| Q4 2025 | 29% | +0.6 points |
| Q3 2025 | 26% | -1.8 points |
| Q2 2025 | 26% | +3.3 points |
| Q1 2025 | 22% | +0.1 points |
| Q4 2024 | 28% | +5.4 points |
GRMN's operating margin was 31% last quarter, up 5 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over GRMN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over GRMN on profitability, with a higher operating margin.
GRMN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $293.3M | -31% |
| Q2 2026 | $275.8M | +116% |
| Q1 2026 | $469.4M | +23% |
| Q4 2025 | $429.6M | +7.6% |
| Q3 2025 | $425.1M | +94% |
| Q2 2025 | $127.5M | -42% |
| Q1 2025 | $380.7M | -5.3% |
| Q4 2024 | $399.2M | -4.3% |
GRMN's free cash flow has been positive every quarter for seven years: $1.5B over the past year, up 10% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over GRMN on cash flow, with more consistent year-over-year improvement.
GRMN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +146K shares |
| 1 year | 0% | +84K shares |
| 3 years | +1.1% | +2M shares |
| 5 years | +0.4% | +807K shares |
| Available history | +1.4% | +2.7M shares |
GRMN has 194M diluted shares, about the same as a year ago.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over GRMN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
GRMN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
GRMN has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
GRMN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.5 | Neutral |
| Stochastic | 44.8 | Neutral |
GRMN's weekly RSI is 56 (neutral) and its Stochastic is 45 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
GRMN PE vs Technology Sector
| Metric | GRMN | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 1.3% below |
| PE % | 86 | 35 | 51 pts above |
GRMN is trading at 27x earnings, in line with the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over GRMN on valuation relative to its sector.
GRMN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $283.3 | 1% above |
| 20 week MA | $278.6 | 2.7% above |
| 50 week MA | $248.6 | 15% above |
| 100 week MA | $232.3 | 23% above |
| 200 week MA | $183.4 | 56% above |
GRMN has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
GRMN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.5 | $120.2 | +22% |
| 2021 | $120.2 | $134.5 | +12% |
| 2022 | $134.5 | $91.3 | -32% |
| 2023 | $91.3 | $128.5 | +41% |
| 2024 | $128.5 | $209.4 | +63% |
| 2025 | $209.4 | $205.5 | -1.8% |
| 2026 YTD | $205.5 | $286.2 | +39% |
GRMN has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.